D-1032-2016 Class III Terminated

Recalled by Valeant Pharmaceuticals North America LLC — Bridgewater, NJ

Recall Details

Product Type
Drugs
Report Date
June 22, 2016
Initiation Date
May 23, 2016
Termination Date
September 12, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3827 bottles

Product Description

Lodrane D (Brompheniramine maleate 4 mg and Pseudoephedrine HCl 60 mg) Capsules, 60-count bottles, Distributed by: Valeant Pharmaceuticals North America LLC, Bridgewater, NJ 08807, UPC 0 00950 86006 8.

Reason for Recall

Labeling: Not Elsewhere Classified: correctly labeled bottles were packaged in cartons that were mislabeled with an incorrect active ingredient, phenylephrine rather than pseudoephedrine, on the carton face and carton top.

Distribution Pattern

Nationwide

Code Information

Lot #'s P0230-022R, P0230-023R, Exp 06/17